Aurobindo Pharma Limited — Updates, 01-05-2026: General Updates

Aurobindo's subsidiary CuraTeQ Biologics secured Health Canada approval for its cancer biosimilar, Bevqolva™. This expands its market presence to Canada, following its UK launch. Further biosimilar applications are currently under review.